| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |